Article Correctness Is Author's Responsibility: Rimegepant Orally Dissolving Tablet Beneficial in Phase 3 Migraine Trial

The article below may contain offensive and/or incorrect content.

Positive topline results were announced from a Phase 3 trial evaluating the safety and efficacy of rimegepant Zydis orally dissolving tablet for the acute treatment of migraine.